Post-stroke infections exacerbate ischemic brain injury in middle-aged rats: Immunomodulation and neuroprotection by progesterone

Neuroscience

Volumn 239, Issue , 2013, Pages 92-102

  Yousuf, S ^a   Atif, F ^a   Sayeed, I ^a   Wang, J ^a   Stein, D G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BDNF; Immunodepression; LPS; Post stroke infection; Progesterone

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; P 0130; PROGESTERONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BEHAVIORAL SCIENCE; BRAIN INFARCTION SIZE; BRAIN INFECTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY REPERFUSION; DISEASE EXACERBATION; FUNCTIONAL STATUS; GRIP STRENGTH; IMMUNOMODULATION; INFLAMMATION; LOCOMOTION; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR COORDINATION; NERVOUS SYSTEM PARAMETERS; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; REGULATORY MECHANISM;

ANIMALS; BRAIN ISCHEMIA; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYTOKINES; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; NEUROPROTECTIVE AGENTS; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; STROKE;

EID: 84876077677     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.10.017     Document Type: Article

References (88)

1. Abe K., Hayashi T. Expression of the glial cell line-derived neurotrophic factor gene in rat brain after transient MCA occlusion. Brain Res 1997, 21:230-234.
2. Althaus H.H., Kloppner S., Klopfleisch S., Schmitz M. Oligodendroglial cells and neurotrophins: a polyphonic cantata in major and minor. J Mol Neurosci 2008, 35:65-79.
3. Atif F, Yousuf S, Sayeed I, Ishrat T, Hua F, Stein DG (in press) Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: the Role of BDNF/TrkB/Erk1/2 signaling in neuroprotection. Neuropharmacology.
4. Bayas A., Hummel V., Kallmann B.A., Karch C., Toyka K.V., et al. Human cerebral endothelial cells are a potential source for bioactive BDNF. Cytokine 2002, 19:55-58.
5. Béjot Y., Mossiat C., Giroud M., Prigent-Tessier A., Marie C. Circulating and brain BDNF levels in stroke rats. Relevance to clinical studies. PLoS One 2011, 6:e29405.
6. Bhat N.R., Zhang P., Lee J.C., Hogan E.L. Extracellular signal-regulated kinase and p38 subgroups of mitogen activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 1998, 18:1633-1641.
7. Boje K.M., Arora P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 1992, 587:250-256.
8. Cekic M., Cutler S.M., VanLandingham J.W., Stein D.G. Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats. Neurobiol Aging 2011, 32:864-874.
9. Chamorro A., Amaro S., Vargas M., Obach V., Cervera A., Gomez-Choco M., Torres F., Planas A.M. Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci 2007, 252:29-35.
10. Chen J., Zhang C., Jiang H., Li Y., Zhang L., Robin A., Katakowski M., Lu M., Chopp M. Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Cereb Blood Flow Metab 2005, 25:281-290.
11. Coughlan T., Gibson C., Murphy S. Progesterone, BDNF and neuroprotection in the injured CNS. Int J Neurosci 2009, 119:1718-1740.
12. Dénes A., Ferenczi S., Kovács K.J. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood-brain barrier damage and brain oedema independently of infarct size. J Neuroinflamm 2011, 8:164.
13. Di Lazzaro V., Profice P., Pilato F., Dileone M., Florio L., et al. BDNF plasma levels in acute stroke. Neurosci Lett 2007, 422:128-130.
14. Dziennis S., Mader S., Akiyoshi K., Ren X., Ayala P., Burrows G.G., Vandenbark A.A., Herson P.S., Hurn P.D., Offner H.A. Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice. Metab Brain Dis 2011, 26:123-133.
15. Emsley H.C.A., Smith C.J., Gavin C.M., Georgiou R.F., Vail A., Barberan E.M., Hallenbeck J.M., del Zoppo G.J., Rothwell N.J., Tyrrell P.J., Hopkins S.J. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 2003, 139:93-101.
16. Emsley H.C., Hopkins S.J. Acute ischemic stroke and infection: recent and emerging concepts. Lancet Neurol 2008, 7:341-353.
17. Elfving B., Plougmann P.H., Müller H.K., Mathé A.A., Rosenberg R. Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. Int J Neuropsychopharmacol 2010, 13:563-572.
18. Fujimura H., Altar C.A., Chen R., Nakamura T., Nakahashi T., et al. Brain derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 2002, 87:728-734.
19. Gibson C.L., Murphy S.P. Progesterone enhances functional recovery after middle cerebral artery occlusion in male mice. J Cereb Blood Flow Metab 2004, 24:805-813.
20. Gibson C.L., Constantin D., Prior M.J., Bath P.M., Murphy S.P. Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Exp Neurol 2005, 193:522-530.
21. Gibson C.L., Coomber B., Murphy S.P. Progesterone is neuroprotective following cerebral ischaemia in reproductively ageing female mice. Brain 2011, 134:2125-2133.
22. González S.L., González Deniselle F., Labombarda M.C., Guennoun R., Schumacher M., De Nicola A.F. Progesterone up-regulates neuronal brain-derived neurotrophic factor expression in the injured spinal cord. Neuroscience 2004, 125:605-614.
23. Grau A.J., Buggle F., Schnitzler P., Spiel M., Lichy C., Hacke W. Fever and infection early after ischemic stroke. J Neurol Sci 1999, 171:115-120.
24. Greenberg M.E., Xu B., Lu B., Hempstead B.L. New insights in the biology of BDNF synthesis and release: implications in CNS function. J Neurosci 2009, 29:12764-12767.
25. Harms H., Prass K., Meisel C., Klehmet J., Rogge W., Drenckhahn C., Gohler J., Bereswill S., Gobel U., Wernecke K.D., Wolf T., Arnold G., Halle E., Volk H.D., Dirnagl U., Meisel A. Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One 2008, 3:e2158.
26. Harms H., Reimnitz P., Bohner G., Werich T., Klingebiel R., Meisel C., Meisel A. Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection. Cerebrovasc Dis 2011, 32:552-560.
27. Hill W.D., Hess D.C., Carroll J.E., Wakade C.G., Howard E.F., Chen Q., Cheng C., Martin-Studdard A., Waller J.L., Beswick R.A. The NF-kappaB inhibitor diethyldithiocarbamate (DDTC) increases brain cell death in a transient middle cerebral artery occlusion model of ischemia. Brain Res Bull 2001, 55:375-386.
28. Hu Y., Russek S.J. BDNF and the diseases nervous system: a delicate balance between adaptative and pathological process of gene regulation. J Neurochem 2008, 105:1-17.
29. Hua F., Wang J., Ishrat T., Wei W., Atif F., Sayeed I., Stein D.G. Genomic profile of Toll-like receptor pathways in traumatically brain-injured mice: effect of exogenous progesterone. J Neuroinflamm 2011, 8:42.
30. Ishrat T., Sayeed I., Atif F., Hua F., Stein D.G. Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway. Neuroscience 2012, 210:442-450.
31. Ishrat T., Sayeed I., Atif F., Hua F., Stein D.G. Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp Neurol 2010, 226:183-190.
32. Ishrat T., Sayeed I., Atif F., Stein D.G. Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats. Brain Res 2009, 1257:94-101.
33. Jiang Y., Wei N., Lu T., Zhu J., Xu G., Liu X. Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats. Neurosci 2011, 172:398-405.
34. Jimenez I., Sobrino T., Rodrigez-Yanez M., Pouso M., Cristobo M., et al. High serum levels of leptin are associated with post-stroke depression?. Psychol Med 2009, 39:1201-1209.
35. Jodha P.K., Kaur P., Underwood W., Lydon J.P., Singh M. The differences in neuroprotective efficacy of progesterone and medroxyprogesterone acetate correlate with their effects on brain-derived neurotrophic factor expression. Endocrinology 2009, 150:3162-3168.
36. Kaur P., Jodhka P.K., Underwood W.A., Bowles C.A., de Fiebre N.C., de Fiebre C.M., Singh M. Progesterone increases brain-derived neurotrophic factor expression and protects against glutamate toxicity in a mitogen-activated protein kinase- and phosphoinositide-3 kinase-dependent manner in cerebral cortical explants. J Neurosci Res 2007, 85:2441-2449.
37. Kajiya M., Shiba H., Fujita T., Takeda K., Uchida Y., Kawaguchi H., Kitagawa M., Takata T., Kurihara H. Brain-derived neurotrophic factor protects cementoblasts from serum starvation-induced cell death. J Cell Physiol 2009, 221:696-706.
38. Karege F., Schwald M., Cisse M. Postnatal developmental profile of brain derived neurotrophic factor in rat brain and platelets. Neurosci Lett 2002, 328:261-264.
39. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J Exp Med 1999, 189:865-870.
40. Kim Y., Busto R., Dietrich W.D., Kraydieh S., Ginsberg M.D. Delayed postischemic hyperthermia in awake rats worsens the histopathological outcome of transient focal cerebral ischemia. Stroke 1996, 27:2274-2280.
41. Koennecke H.C., Belz W., Berfelde D., Endres M., Fitzek S., Hamilton F., Kreitsch P., Mackert B.M., Nabavi D.G., Nolte C.H., Pohls W., Schmehl I., Schmitz B., von Brevern M., Walter G., Heuschmann P.U. Factors influencing inhospital mortality and morbidity in patients treated on a stroke unit. Neurology 2011, 77:965-972.
42. Kumar S., Selim M.H., Caplan L.R. Medical complications after stroke. Lancet Neurol 2010, 9:105-118.
43. Langdon K.D., Maclellan C.L., Corbett D. Prolonged, 24-h delayed peripheral inflammation increases short- and long-term functional impairment and histopathological damage after focal ischemia in the rat. J Cereb Blood Flow Metab 2010, 30:1450-1459.
44. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
45. Luo K.R., Hong C.J., Liou Y.J., Hou S.J., Huang Y.H., et al. Differential regulation of neurotrophin S100B and BDNF in two rat models of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 2010, 34:1433-1439.
46. MacLellan C.L., Davies L.M., Fingas M.S., Colbourne F. The influence of hypothermia on outcome after intracerebral hemorrhage in rats. Stroke 2006, 37:1266-1270.
47. Makar T.K., Bever C.T., Singh I.S., Royal W., Sahu S.N., Sura T.P., Sultana S., Sura K.T., Patel N., Dhib-Jalbut S., Trisler D. Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle. J Neuroimmunol 2009, 210:40-51.
48. Marsh B., Stevens S.L., Packard A.E., Gopalan B., Hunter B., Leung P.Y., Harrington C.A., Stenzel-Poore M.P. Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J Neurosci 2009, 29:9839-9849.
49. Mathers C.D., Boerma T., Ma Fat D. Global and regional causes of death. Br Med Bull 2009, 92:7-32.
50. Mattson M.P., Maudsley S., Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 2004, 27:589-594.
51. McColl B.W., Rothwell N.J., Allan S.M. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J Neurosci 2007, 27:4403-4412.
52. McColl B.W., Rothwell N.J., Allan S.M. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci 2008, 28:9451-9462.
53. Meisel C., Schwab J.M., Prass K., Meisel A., Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005, 6:775-786.
54. Meisel C., Meisel A. Suppressing immunosuppression after stroke. N Engl J Med 2011, 365:2134-2136.
55. Meisel A., Meisel C., Harms H., Hartmann O., Ulm L. Predicting post-stroke infections and outcome with blood-based immune and stress markers. Cerebrovasc Dis 2012, 33:580-588.
56. Meyer M., Gonzalez Deniselle M.C., Gargiulo-Monachelli G., Garay L.I., Schumacher M., Guennoun R., De Nicola A.F. Progesterone effects on neuronal brain-derived neurotrophic factor and glial cells during progression of Wobbler mouse neurodegeneration. Neuroscience 2012, 201:267-279.
57. Miller L., Alley E.W., Murphy W.J., Russell S.W., Hunt J.S. Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages. J Leukoc Biol 1996, 59:442-450.
58. Mizuno M., Yamada K., Olariu A., Nawa H., Nabeshima T. Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. J Neurosci 2000, 20:7116-7121.
59. Moralí G., Montes P., González-Burgos I., Velázquez-Zamora D.A., Cervantes M. Cytoarchitectural characteristics of hippocampal CA1 pyramidal neurons of rats, four months after global cerebral ischemia and progesterone treatment. Restor Neurol Neurosci 2012, 30:1-8.
60. Nakahashi T., Fujimura H., Altar C.A., Li J., Kambayashi J., et al. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 2000, 470:113-117.
61. Offner H., Subramanian S., Parker S.M., Wang C., Afentoulis M.E., Lewis A., Vandenbark A.A., Hurn P.D. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 2006, 176:6523-6531.
62. Polderman K.H. Induced hypothermia and fever control for prevention and treatment of neurological injuries. Lancet 2008, 371:1955-1969.
63. Prass K.C., Meisel C.H., Braun J., Halle E., Wolf T., Ruscher K., Victorov I.V., Priller J., Dirnagl U., et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003, 198:725-736.
64. Prass K., Braun J.S., Dirnagl U., Meisel C., Meisel A. Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 2006, 37:2607-2612.
65. Robert R., Spitzer J.A. Effects of female hormones (17beta-estradiol and progesterone) on nitric oxide production by alveolar macrophages in rats. Nitric oxide 1997, 1:453-462.
66. Sayeed I., Guo Q., Hoffman S.W., Stein D.G. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion. Ann Emerg Med 2006, 47:381-389.
67. Sayeed I., Stein D.G. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog Brain Res 2009, 175:219-237.
68. Sayeed I., Wali B., Stein D.G. Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restor Neurol Neurosci 2007, 25:151-159.
69. Shi Q., Zhang P., Zhang J., Chen X., Lu H., Tian Y., Parker T.L., Liu Y. Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice. Neurosci Lett 2009, 465:220-225.
70. Sieber M.W., Claus R.A., Witte O.W., Frahm C. Attenuated inflammatory response in aged mice brains following stroke. PLoS One 2011, 6:e26288.
71. Smith C.J., Emsley H.C., Gavin C.M., Georgiou R.F., Vail A., Barberan E.M., del Zoppo G.J., Hallenbeck J.M., Rothwell N.J., Hopkins S.J., Tyrrell P.J. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 2004, 4:2.
72. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 2001, 24:1217-1281.
73. Spencer S.J., Mouihate A., Pittman Q.J. Peripheral inflammation exacerbates damage after global ischemia independently of temperature and acute brain inflammation. Stroke 2007, 38:1570-1577.
74. Stein D.G. Progesterone exerts neuroprotective effects after brain injury. Brain Res Rev 2008, 57:386-397.
75. Stein DG (2012) A clinical/translational perspective: can a developmental hormone play a role in the treatment of traumatic brain injury? Horm Behav. [epub ahead of print].
76. Su C., Cunningham R.L., Rybalchenko N., Singh M. Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling. Endocrinology 2012, 153:4389-4400.
77. Swiatek-De Lange M., Stampfl A., Hauck S.M., Zischka H., Gloeckner C.J., Deeg C.A., Ueffing M. Membrane-initiated effects of progesterone on calcium dependent signaling and activation of VEGF gene expression in retinal glial cells. Glia 2007, 55:1061-1073.
78. Valerio A., Dossena M., Bertolotti P., Boroni F., Sarnico I., Faraco G., Chiarugi A., Frontini A., Giordano A., Liou H.C., De Simoni M.G., Spano P., Carruba M.O., Pizzi M., Nisoli E. Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NFkappaB/c-Rel-dependent transcription. Stroke 2009, 40:610-617.
79. Wang H., Ward N., Boswell M., Katz D.M. Secretion of brain-derived neurotrophic factor from brain microvascular endothelial cells. Eur J Neurosci 2006, 23:1665-1670.
80. Wang J., Zhao Y., Liu C., Jiang C., Zhao C., Zhu Z. Progesterone inhibits inflammatory response pathways after permanent middle cerebral artery occlusion in rats. Mol Med Rep 2011, 4:319-324.
81. Westendorp W.F., Vermeij J.D., Vermeij F., Den Hertog H.M., Dippel D.W., van de Beek D., Nederkoorn P.J. Antibiotic therapy for preventing infections in patients with acute stroke. Cochrane Database Syst Rev 2012, 1:CD008530.
82. Woiciechowsky C., Asadullah K., Nestler D., Eberhardt B., Platzer C., Schoning B., Glockner F., Lanksch W.R., Volk H.D., Docke W.D. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 1998, 4:808-813.
83. Wright D.W., Kellermann A.L., Hertzberg V.S., Clark P.L., Frankel M., Goldstein F.C., Salomone J.P., Dent L.L., Harris O.A., Ander D.S., Lowery D.W., Patel M.M., Denson D.D., Gordon A.B., Wald M.M., Gupta S., Hoffman S.W., Stein D.G. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 2007, 49:391-402.
84. Xiao G., Wei J., Yan W., Wang W., Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 2008, 12:R61.
85. Yang L., Zhang Z., Sun D., Xu Z., Yuan Y., et al. Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke. Int J Geriatr Psychiatry 2011, 26:495-502.
86. Yeiser E.C., Rutkoski N.J., Naito A., Inoue J., Carter B.D. Neurotrophin signaling through the p75 receptor is deficient in traf6-/- mice. J Neurosci 2004, 24:10521-10529.
87. Zhang J., Geula C., Lu C., Koziel H., Hatcher L.M., Roisen F.J. Neurotrophins regulate proliferation and survival of two microglial cell lines in vitro. Exp Neurol 2003, 183:469-481.
88. Zhou Z., Lu T., Yue X., Zhu W., Ma M., et al. Decreased serum-brain derived neurotrophic factor (BDNF) is associated with post-stroke depression but not with BDNF gene Val66met polymorphism. Clin Chem Lab Med 2011, 49:185-189.